XM does not provide services to residents of the United States of America.

Holiday company Saga in talks with Ageas about insurance partnership



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Holiday company Saga in talks with Ageas about insurance partnership</title></head><body>

Saga says no certainty deal will go through

Postpones HY results

Shares rise as much as 14.4%

Adds shares in paragraph 1 and 3, detail on Ageas in paragraph 5

Oct 2 (Reuters) -British holiday group Saga SAGA.L said on Wednesday that it is in talks with Belgian insurer Ageas AGES.BR about a potential partnership for its insurance business, sending Saga's shares up more than 14%.

Saga, which specialises in holidays and insurance for people over 50, has faced challenges in its insurance business and has taken steps, including increasing prices in insurance underwriting and reducing staff to control costs.

Saga's shares rose as much as 14.4% to 128.8 pence in early trade. They are down 18% so far this year.

The potential partnership follows Ageas' unsuccessful attempt to buy UK rival Direct Line in a 3.17 billion pound bid in March.

Ageas, which presented a new strategic plan in September, is aiming to capitalise on the growing demand for pension and savings products from aging populations in Europe and Asia.

Sky News, which first reported on the talks between the two companies on Tuesday, said that under the proposed deal, Ageas would make an up-front payment to Saga.

Saga did not disclose the amount in its statement on Wednesday and said it was not certain that the deal would take place.

In September last year, Saga put a sale process on hold for its insurance underwriting arm, whose potential sale to Australia's Open was terminated earlier in 2023.

Separately, Saga postponed its half-year results that were due on Wednesday, but said its first-half performance was in-line with its expectations.

It did not give a date for publication of the results.

($1 = 0.7530 pounds)



Reporting by Yamini Kalia and Surbhi Misra in Bengaluru; Editing by Mohammed Safi Shamsi, Sonia Cheema and Jane Merriman

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.